Table 1 Characteristics of 152 AAV patients and the healthy control group of individuals
AAV (n = 152) | Control (n = 150) | P | |
|---|---|---|---|
Female, n(%) | 78 (51.32) | 76 (50.67) | 0.910 |
Male, n (%) | 74 (48.68) | 74 (49.33) | |
Age, years, mean (S.D.) | 64.07 (14.81) | 63.56 (13.67) | 0.755 |
Organs involvement, n (%) | |||
Eye | 15 (9.87) | – | – |
ENT | 50 (32.89) | – | – |
Pulmonary | 116 (76.32) | – | – |
Cardiovascular | 10 (6.58) | – | – |
Abdominal | 11 (7.24) | – | – |
Renal | 85 (55.92) | – | – |
Cutaneous | 10 (6.58) | – | – |
Musculoskeletal | 44 (28.95) | – | – |
Nervous | 16 (10.53) | – | – |
MPO-ANCA, n (%) | 127 (83.55) | – | – |
PR3-ANCA, n (%) | 25 (16.45) | – | – |
Died, n (%) | 23 (15.13) | – | – |